Page 764«..1020..763764765766..770780..»

Anti-Osteoporosis Therapy and Fracture Healing Market is Expected to Witness a CAGR of 5.0% by 2026 – PharmiWeb.com

Posted: February 23, 2021 at 3:46 am

Future Market Insights has recently published a report titled Anti-Osteoporosis Therapy and Fracture Healing Market: Global Industry Analysis (2012 2017) and Opportunity Assessment (2018 2026). The report states that despite the uncertainty in terms of political and economic scenario, the global healthcare industry is expected to receive a positive push from sectors such as medical imaging, in-vitro diagnostics, biotech and pharmaceuticals, and medical devices.

Key markets across the world are facing an enormous rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits. A speedily multiplying geriatric population, growing prevalence of chronic ailments such as cancer and cardiac disease, rising awareness among patients and high investments in clinical innovation are a few of the factors that are impacting the performance of the global healthcare industry at present. As a result of these factors, the global anti-osteoporosis therapy and fracture healing market is expected to witness a CAGR of 5.0% between 2018 and 2026.

Request a Sample Report with Table of Contents and Figures:https://www.futuremarketinsights.com/reports/sample/rep-gb-1008

Growing Geriatric Population to Augur Adoption

Rising prevalence of osteoporosis is considered to be an important factor driving the global market, as the growing number of patients will also increase the demand for drugs and therapy. Furthermore, due to the absence of any substitutes such as surgery, demand for osteoporosis drugs is increasing constantly. According to the International Osteoporosis Foundation, almost 50% of the global bone fracture incidences would occur in the Asia Pacific region by 2050 end. A high occurrence and incidence rate of the disease is considered an important driver for the market. Furthermore, rising geriatric population is considered to be an important factor for the growth of the market in the coming years, although patent expiries of leading brands would considerably slow down the growth rate.

Bisphosphonates to Lead Among Drug Types

The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Among these, bisphosphonates is expected to emerge dominant by the end of 2026 with a valuation of around US$ 5,941 Mn in the same year.

Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-1008

Preview Analysis on Anti-Osteoporosis Therapy and Fracture Healing Market Segmentation By Drug Type Bisphosphonates, Calcitonin, Estrogen or Hormone Replacement Therapy, Biologics, Anabolics; By Route of Administration Type Oral,Injectable; By Distribution Channel Type Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce

Companies to Fight for Patent Rights

Leading companies in the market are competing against each other to gain patent rights on the different novel drugs that are being introduced in the market. This is further expected to intensify competition in the global market in the long run. Some of the companies operating in the global anti-osteoporosis therapy and fracture healing market are Novartis, Johnson and Johnson, GlaxoSmithKline PLC, Roche, Pfizer, MERCK, and AMGEN, among others.

1. Global Anti-Osteoporosis Therapy and Fracture Healing Market Executive Summary

2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Overview

3. Global Anti-Osteoporosis Therapy and Fracture Healing Market Analysis and Forecast 2012-2026

4. North America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

5. Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1008

6. Europe Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

7. Japan Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

8. APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

9. MEA Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

10. Global Anti-Osteoporosis Therapy and Fracture Healing Market Company Share, Competition Landscape and Company Profiles

And So On

Explore Wide-ranging Coverage of FMIsHealthcareMarket Insights Landscape

Quadripodal Implants Market FMIs analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.

Surgical Broaches Market Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.

Surgical Rasps Market FMIs report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries.FMIis headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMIs latestmarket research reportsand industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek BudholiyaUnit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers, Dubai,United Arab EmiratesMARKET ACCESS DMCC InitiativeFor Sales Enquiries:sales@futuremarketinsights.comFor Media Enquiries:press@futuremarketinsights.com

Read more:
Anti-Osteoporosis Therapy and Fracture Healing Market is Expected to Witness a CAGR of 5.0% by 2026 - PharmiWeb.com

Posted in Hormone Replacement Therapy | Comments Off on Anti-Osteoporosis Therapy and Fracture Healing Market is Expected to Witness a CAGR of 5.0% by 2026 – PharmiWeb.com

Seven reasons why you’re feeling bloated – and what you can do to fix it – Stuff.co.nz

Posted: February 23, 2021 at 3:46 am

This article was published on Woman.

Elasticised waists on high rotation in your wardrobe? Work out what could be causing you to feel bloated and how to stop it happening.

We all know the feeling. The uncomfortable, tight, distended belly; the suspicion that your pants weren't so tight when you put them on a few hours ago.

Feeling bloated isn't just something that happens to us after a big dinner (although that's obviously a cause). It can happen for other reasons and there are some simple solutions.

Heres a rundown of what might be causing you to feel bloated, but take note: other serious causes of bloating need to be eliminated if youre struggling with this, so make sure you read right to the last paragraph and dont self-diagnose.

READ MORE:* Living with an inflammatory bowel disease and all the unglamorous symptoms that come with it* What you need to know about coeliac disease* US bodybuilder reveals before and after photos of bloating after eating trigger foods* A guide to the fundamental dos and don'ts for IBS sufferers

We swallow air when we eat too quickly, drink fizzy drinks (including sparkling water) and chew gum, and it can make its way to our belly, causing us to feel bloated. Stopping it from happening is an easy fix just cut out the bubbly drinks and gum, and try to take your time over meals. And chew properly!

avemario/123RF

Finding ways to manage stress can help beat the bloat.

Stress is linked to bloating in several ways. It can slow digestion, causing constipation and bloating; it can worsen symptoms in people with irritable bowel syndrome (IBS); and it can cause us to gulp more air.

Finding ways to manage stress can help beat the bloat, and exercise is a great place to start, as it has the additional benefit of helping to get your gut moving.

Being constipated is pretty uncomfortable. Its also super common, and can often be the reason for feeling as if youre constantly bloated. Even if you think youre regular, you might still be slightly backed up, especially if youre also experiencing a bit of pain and wind. The remedy? Pay attention to your poo. If its not sausage-shaped, reasonably large, soft, and easy to pass, it could be that things are not functioning as well as they should be. Small, hard stools might be dainty, but theyre not optimal.

Fix bloating by cleaning up your diet and adding more high-fibre foods: wholegrains, nuts, seeds, vegetables and fruit. If youre eating white versions of foods such as bread, pasta or rice, switch to the wholegrain versions. And dont forget beans, chickpeas and lentils - they're fibre superstars.

Edward Howell/Unsplash

Fibre is essential for a happy tummy.

If you increase your fibre intake, up the amount of water you drink too. Fibre needs water to help it along, and suddenly adding extra fibre without boosting your hydration as well is a recipe for more trouble.

Some foods can cause us to get gassy, which can make us feel bloated.

Despite their superstar status, beans are common culprits because of the oligosaccharides they contain, and their beneficial fibre can cause trouble for some people, including those who are prone to IBS.

Charlotte Karlsen/Unsplash

Some foods can cause us to get gassy, which can make us feel bloated.

If we can, though, were better off including beans, chickpeas and lentils in our diets for their fibre and probiotics, which are good food for our gut bacteria. Try canned versions especially when it comes to lentils and black beans which have been found to cause fewer symptoms.

Introducing these foods to your diet gradually can ease the severity of any bloating you might experience. If youre really having trouble and cant pinpoint a food source, check out the low-FODMAP diet for IBS.

We cant discount a link between a bloated tum and our hormones, especially at midlife. IBS is much more common in women in the perimenopause years (40s to early 50s), and younger women sometimes report gut symptoms around menstruation.

Thats likely due to the connection between our hormones and fluid retention. Higher oestrogen levels can cause water retention, and bloating can also be a side effect when women first start hormone replacement therapy (HRT), though this should ease.

David Alexander/Stuff

Some women experience bloating when they start hormone replacement therapy.

Although bloating is usually more of an annoyance than a major problem, in some cases it can be a sign of something more serious, so if youve been feeling bloated for an extended period of time or its come on suddenly, get yourself checked out.

As well as IBS, bloating can be a symptom of coeliac disease, and its also associated with one of the trickiest cancers to detect affecting women, ovarian cancer. So if youre not feeling right, dont ignore it.

Continued here:
Seven reasons why you're feeling bloated - and what you can do to fix it - Stuff.co.nz

Posted in Hormone Replacement Therapy | Comments Off on Seven reasons why you’re feeling bloated – and what you can do to fix it – Stuff.co.nz

Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells – PRNewswire

Posted: February 23, 2021 at 3:44 am

ELK CITY, Idaho, Feb. 22, 2021 /PRNewswire/ --Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today novel data and filing of a patent application demonstrating that StemVacs cells carrying proprietary sequences from the cancer-specific antigen Brother of the Regulator of Imprinted Sites (BORIS), were able to elicit the generation of T cells capable of selectively killing cancer stem cells.

In contrast to other markers associated with cancer, BORIS is not simply a "flag" that is recognized by the immune system, but it is essential for cancer to be cancer. Dr. Thomas Ichim, Board Member of the Company, published that gene silencing of BORIS resulted in the death of cancer cells.1 National Institutes of Health Scientist Dr. Dmitri Loukinov, as well as other collaborators, published with Dr. Ichim that DNA immunization with BORIS resulted in suppression of aggressive breast cancer,2 as well as induction of T cells capable of killing glioma, leukemia, and mastocytoma.3

"Despite living in what is called the Golden Age of Immunotherapy, the majority of cancers still do not undergo substantial responses to current treatments," said Dr. James Veltmeyer, Chief Medical Officer of the Company and co-inventor of the patent application. "What is impressive about the StemVacs approach is that it can generate personalized T cells that selectively seek and destroy cancer stem cells. It is the cancer stem cells that are the 'roots' of the cancer. They are resistant to chemotherapy and radiotherapy and to my knowledge the only possible way of eliminating cancer stem cells is through immunotherapy."

"Having worked in the area of cellular therapy and vaccine development, the possibility of using an allogeneic dendritic cell-based approach to ex vivo generate cancer stem cell killing T effector cells is tantalizing," said Feng Lin, MD, Ph.D., Chief Scientific Officer of the Company. "I look forward to continuation of these studies and eventual clinical utilization."

Researchers believe current cancer treatments sometimes fail because they don't destroy the cancer stem cells. Think of cancer as a weed: the stem cells are the root while the remaining majority of the cells are the part of the weed above ground. If you remove only the leaves but not the root, the weed will grow back. The same is true for cancer: if you do not kill the cancer stem cells, the cancer is likely to return.4

"Cellular therapy is the future of medicine," said Famela Ramos, Vice President of Business Development of the Company and co-inventor of the patent. "This demonstration that StemVacs can generate "patient specific" killer cells that can be reinfused in patients offers a new area of product development for us, as well as an ability to implement a two-punch attack on the tumor."

"At Therapeutic Solutions International we are focused on researching, patenting, and implementing the most innovative and potentially effective immunotherapies we can develop," said Timothy Dixon, President and CEO of the Company and co-inventor of the patent. "The ability to generate tailor-made killer T cells that appear to selectively target cancer stem cells provides yet another complementary cellular immunotherapy in our growing armamentarium against this terrible disease."

About Therapeutic Solutions International, Inc.Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is http://www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/

[emailprotected]

1 Selective apoptosis of breast cancer cells by siRNA targeting of BORIS - PubMed (nih.gov)2 DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice (nih.gov)3 Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites | The Journal of Immunology (jimmunol.org)4 Cancer Stem Cell Research | University of Michigan Rogel Cancer Center

SOURCE Therapeutic Solutions International

therapeuticsolutionsint.com

See more here:
Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells - PRNewswire

Posted in Idaho Stem Cells | Comments Off on Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells – PRNewswire

Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering – The Times of Israel

Posted: February 23, 2021 at 3:43 am

An Israeli-made nasal spray appears to have contributed to a reduced COVID-19 infection rate among ultra-Orthodox members of a synagogue in Bnei Brak amid Rosh Hashanah festivities last year, a new trial has shown.

Of 83 worshipers who used the spray as instructed before Rosh Hashanah prayers and for the following two weeks, just two contracted the highly contagious virus, in a real-world test of the substance which is designed to create a protective gel layer over the nasal mucosa to blocks viruses from infecting the nasal cells. The study was conducted by makers of the Taffix spray, Nasus Pharma, along with scientists from the University of Haifa, the University of Virginia, and the Hadassah Medical Center in Jerusalem. The full study was initially published in November 2020, with an updated version posted last month.

According to the study, Nasus Pharma approached a medium-sized synagogue community of some 250 members in Bnei Brak ahead of Rosh Hashanah in September 2020 to gauge their interest in participating in the trial involving the spray, which was touted as an extra layer of protection. Each member was eligible to collect a bottle of Taffix at the synagogue the day before Rosh Hashana prayers and received written instructions on the proper usage of the spray.

Get The Start-Up Israel's Daily Start-Up by email and never miss our top storiesFree Sign Up

At the time, Israel was a world leader in the number of new COVID-19 cases per million citizens, and the infection rate among ultra-orthodox communities was double that of the general population. Since Rosh Hashanah is characterized by mass prayers in synagogues and family events, there were concerns about Jewish high holiday events as potential post-mass gathering outbreaks, especially in ultra-Orthodox communities. Before the holiday in mid-September, Bnei Braks positivity rates for COVID-19 were 17.6%, climbing to 28.1% two weeks later, the study showed.

Ultra-Orthodox Jews are pictured praying in a synagogue divided with plastic sheets in Bnei Brak, near Tel Aviv, amid measures put in place to stem the spread of Covid-19 on September 7, 2020. (Menahem Kahana/AFP)

This is a community that has different priorities and values, Nasus Pharma CEO Dr. Dalia Megiddo told The Times on Friday. Although the government tried to explain and to enlist opinion leaders, it was very clear they were going to go to the synagogue come what may. So we said, OK, this is going to be a super-spreader event.'

At the end of the two-week trial, 81 of the 83 members of the synagogue who used the spray as instructed every five hours whenever they left their residences for the following 14 days did not contract the virus. The two who did get infected rarely used the spray, and the remaining members of the community did not use Taffix at all.

These important results conform with prior in vitro studies performed with Taffix that proved its robust activity against the transmission of SARS-CoV-2 , Dr. Megiddo said in an announcement in October. This is the first clinical real-life data showing that the use of Taffix is highly effective even in the worst-case scenario of a super spread event in the heart of the worst-hit city in Israel.

In previous lab studies with Taffix, the spray was shown to be 99% percent effective in blocking viruses, including SARS-CoV-2, from infecting human cells, Nasus Pharma had indicated. The spray has been approved for use in Israel since last July and has a CE mark for use in Europe.

Ultra-Orthodox Jews during morning prayer in a synagogue during a nationwide three-week lockdown to curb the spread of the coronavirus, in Bnei Brak, Sept 21, 2020. (AP Photo/Oded Balilty)

Professor Yaakov Naparstek, the scientific director of the Meuhedet HMO Research Institute and a physician at Hadassah Medical Center in Jerusalem who co-authored the study, said that the fact that Taffix was able to significantly reduce infection rate in users of the product is very encouraging.

It may offer an additional layer of protection to people who encounter events that pose high risk of infection. The data contributes to our knowledge of the effect on population protection, he went on, adding that additional controlled clinical studies will be needed to determine specific efficacy in different circumstances.

Given the excellent safety profile of Taffix and its statistically significant efficacy in preventing infection following what is defined as high-risk infection event it seems that this additional layer of protection can significantly reduce the risks of infection and may enable people to resume some part of their daily routine more safely, the authors wrote.

The Israeli-made nasal spray Taffix is said to reduce infection risk by 99 percent in lab studies, say makers of the product, Nasus Pharma. (Screenshot)

Nasus Pharma is a privately held clinical-stage biopharmaceutical company founded in 2019. Based in Tel Aviv, the company says it is developing a number of intranasal products aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock.

In addition to Taffix, Nasus Pharmas products include Intranasal Naloxone, heading to a phase II trial, and Intranasal Epinephrine, currently in phase II, as well as a number of preclinical products.

I'm proud to work at The Times of Israel

As The Times of Israel's environment reporter, I try to convey the facts and science behind climate change and environmental degradation, to explain - and critique - the official policies affecting our future, and to describe Israeli technologies that can form part of the solution.

I am passionate about the natural world and disheartened by the dismal lack of awareness to environmental issues shown by most of the public and politicians in Israel.

I'm proud to be doing my part to keep The Times of Israel's readers properly informed about this vital subject.

Your support, through membership in The Times of Israel Community, enables us to continue our important work. Would you join our Community today?

Thank you,

Sue Surkes, Environment Reporter

Youre serious. We appreciate that!

Were really pleased that youve read X Times of Israel articles in the past month.

Thats why we come to work every day - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.

So now we have a request. Unlike other news outlets, we havent put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.

For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.

Originally posted here:
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering - The Times of Israel

Posted in Virginia Stem Cells | Comments Off on Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering – The Times of Israel

Hormone Replacement Therapy Market will touch a new level in upcoming year with Top Key players like F. Hoffmann-La Roche, Merck Serono, Novartis,…

Posted: February 19, 2021 at 1:48 am

The study throws light on the Hormone Replacement Therapy market mainly focusing on the growth factors and even the restraining factors. The restraining factors are also provided with the best solutions which also prove to be a counteract to the drawback and help increase the market demand. Applications, types, technology and many other segmentations are studied to give a depth of knowledge for the further market investment. Key driving forces for Hormone Replacement Therapy market is explained to help give an idea for detailed analysis of this market.

The global Hormone Replacement Therapy market is expected to expand at a CAGR of +XX% over the forecast period 2020-2026.

This market research report on the Hormone Replacement Therapy Market is an all-inclusive study of the business sectors up-to-date outlines, industry enhancement drivers, and manacles. It provides market projections for the coming years. It contains an analysis of late augmentations in innovation, Porters five force model analysis and progressive profiles of hand-picked industry competitors. The report additionally formulates a survey of minor and full-scale factors charging for the new applicants in the market and the ones as of now in the market along with a systematic value chain exploration.

Get Sample Copy of this Report @

https://www.reportsnmarkets.com/request_sample.php?id=97221

Top Key Vendors in Market:

This report provides an effective business outlook, different case studies from various top-level industry experts, business owners, and policymakers have been included to get a clear vision about business methodologies to the readers. SWOT and Porters Five model have been used for analyzing the Hormone Replacement Therapy market on the basis of strengths, challenges and global opportunities in front of the businesses.

The global Hormone Replacement Therapy market is analyzed in terms of its competitive landscape. For this, the report encapsulates data on each of the key players in the market according to their current company profile, gross margins, sale price, sales revenue, sales volume, product specifications along with pictures, and the latest contact information. The reports conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Hormone Replacement Therapy market in the near future.

Get Upto 20% Discount on this Report @

https://www.reportsnmarkets.com/ask_for_discount.php?id=97221

Key questions answered in the report include:

Table of Content:

Global Hormone Replacement Therapy Market Research Report 2020-2026

Chapter 1: Industry Overview

Chapter 2: Hormone Replacement Therapy Market International and China Market Analysis

Chapter 3: Analysis of Revenue by Classifications

Chapter 4: Analysis of Revenue by Regions and Applications

Chapter 5: Analysis of Hormone Replacement Therapy Market Revenue Market Status.

Chapter 6: Sales Price and Gross Margin Analysis

Continue for TOC..

Enquiry before buying @

https://www.reportsnmarkets.com/enquiry_before_buying.php?id=97221

Contact Us:

Reports N Markets,

125 High Street, Boston, MA 02110

sales@reportsnmarkets.com

+1 617 671 0092

Continue reading here:
Hormone Replacement Therapy Market will touch a new level in upcoming year with Top Key players like F. Hoffmann-La Roche, Merck Serono, Novartis,...

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy Market will touch a new level in upcoming year with Top Key players like F. Hoffmann-La Roche, Merck Serono, Novartis,…

Global Bio-identical Hormone Replacement Therapy Market Report to Cover Industrial Chain Analysis, Manufacturing Cost Structure, Process Analysis -…

Posted: February 19, 2021 at 1:48 am

The Bio-identical Hormone Replacement Therapy market report, published bySyndicate Market Research, offers an organized assessment of the importantaspects of the global Bio-identical Hormone Replacement Therapy market, serving as a means to the better evaluation of the present and future situations of the market. The report provides a 360-degree outline of the competitive landscape of the Bio-identical Hormone Replacement Therapy market. It also consists of wide-ranging data in relation to the prominent competitors/players (US Compounding, RevitaLife, Aesthetics&Wellness) of the industry. These data comprise numerous companies, organizations, suppliers, manufacturers, and associations competing for supply, production, revenue generation, sales, and after-sales performance opportunities.

Bio-identical Hormone Replacement Therapy Market acquired revenue ofUSD XX million in 2019globally and has been anticipated to produceUSD XX million by 2026at a compound annual growth rate (CAGR) ofxx% over the estimate period.

Get Free PDF Sample Copy of this Report(Including Full TOC with COVID-19 Outbreak Analysis)

Several analytical tools, such as SWOT analysis, have been utilized tocomprehend the Bio-identical Hormone Replacement Therapy market dynamics, assisting the players to take a look at the possible challenges and threats they may face for the businesses during the forecast period. The research report also entails the bargaining power of several buyers and vendors. Following the assessment of the major market players/competitors, the report also highlights the new entrants adding their bit to the expansion of the global Bio-identical Hormone Replacement Therapy market.

The report includes a comprehensive analysis of the main players in the market with their company overview, expansion strategies, and tactics. Key players examined in the report include:

US Compounding, RevitaLife, Aesthetics&Wellness, and more.

The Bio-identical Hormone Replacement Therapy market report also includes an in-depth analysis of the major factors having the potential to drive or hamper the growth of the market along with the latest and possible future trends within the global Bio-identical Hormone Replacement Therapy market. It also encompasses the likely influence of imposing numerous policies and regulations on the growth of the global Bio-identical Hormone Replacement Therapy market.

Report Parameter Description

Apart from this, the research report also dives into the market segmentation. In this section, the report bifurcates the Bio-identical Hormone Replacement Therapy market based on Types (Creams, Injections, Implanted Pellets, Patches, Gels) and Applications (Men, Women) while offering reliable and precise forecasts of these segments potential growth opportunities and share within the market.

Do Inquiry for more information about Bio-identical Hormone Replacement Therapy repor @https://www.syndicatemarketresearch.com/inquiry/bio-identical-hormone-replacement-therapy-market

The assessment can be utilized by market participants to make planned investments in major growing pockets of the global Bio-identical Hormone Replacement Therapy market. The report also divulges analysis of all key regions and countries regions that will further assist the reports buyer to enter the unexplored regional markets, compare the expansion of all regional markets, and get ready with dedicated approaches for target regions.

In this report, we analyze theglobal Bio-identical Hormone Replacement Therapy marketfrom 5 major geographies: Asia-Pacific [India, Japan, Korea, Western Asia, China, Southeast Asia], Europe [Italy, Russia, Spain, Netherlands, Germany, UK, France, Turkey, Switzerland], North America [USA, Canada, Mexico], South America [Chile, Argentina, Columbia, Brazil, Peru], The Middle East & Africa [South Africa, GCC, Rest of MEA].

Comprehensive Coverage of the Bio-identical Hormone Replacement Therapy Market:

To Get Detailed Overview about the Bio-identical Hormone Replacement Therapy report (COVID-19 Impact Analysis), Click @https://www.syndicatemarketresearch.com/market-analysis/bio-identical-hormone-replacement-therapy-market.html

The Bio-identical Hormone Replacement Therapy market report sheds light on the market share with prediction related to the growth rate of the market during the past years and forecast period. The report also takes into consideration the influence of the COVID-19 pandemic that will assist investors and shareholders in making knowledgeable decisions.

Top to bottom qualitative analysis include identification and research of the following features:

To conclude, the report buyers will have access to confirmed and precise estimations of the total size of the Bio-identical Hormone Replacement Therapy market in terms of volume and value. It also puts forth diverse approaches to discover the opportunities, weaknesses, strengths, and threats impacting market growth.

Read also :https://adalidda.com/posts/WZcvSQpkSeoCmLAm4/global-maritime-tourism-market-covid-19-analysis-industry

As per your requirement,Syndicate Market Researchpresents the customization of reports. This report can be embodied to satisfy your needs. Contact our sales team ([emailprotected]), who will assure you to get a report that satisfies your requirements.

View post:
Global Bio-identical Hormone Replacement Therapy Market Report to Cover Industrial Chain Analysis, Manufacturing Cost Structure, Process Analysis -...

Posted in Hormone Replacement Therapy | Comments Off on Global Bio-identical Hormone Replacement Therapy Market Report to Cover Industrial Chain Analysis, Manufacturing Cost Structure, Process Analysis -…

Suffering with Premature Ovarian Insufficiency (POI) in the workplace – Open Access Government

Posted: February 19, 2021 at 1:48 am

Unfortunately, Premature Ovarian Insufficiency (POI) is a condition which isnt widely talked about, despite its prevalence. It is estimated that POI occurs in around 1 in 100 women under the age of 40, 1 in 1000 women under the age of 30 and 1 in 10,000 women under the age of 20. There are far-reaching physical and emotional consequences for sufferers of POI. The condition can result in a lower quality of life, impacting sexuality, mental and cognitive health, fertility, bone health and cardiovascular health.

More than ever, women are a valuable and vital asset to the workforce, but the reality is our behaviour is driven by our hormones and we have to navigate that rollercoaster from puberty, motherhood and then menopause. The journey is often unpredictable but especially when the menopausal period is brought forward bringing different issues that need support into the spotlight. Education for employers, women and men is key about the impact of womens hormones and how workplace culture needs to adapt to celebrate diversity, inclusivity and bridge the gender gap.

POI results in decreased sex hormone production as ovulation is brought to a halt. Sex hormones (estrogen, progesterone and testosterone) are crucial to our health and this cannot be emphasised enough. Often the cause of POI is unknown or genetic but it can be a cruel side effect of gynaecological surgery, particularly endometrial or ovarian cancer. Other cancer treatments such as chemotherapy or pelvic radiation are also implicated. There is a link of POI with diabetes, thyroid conditions, and autoimmune disorders so superimposing this on pre-existing health challenges is a double blow. Both underdiagnosis and misdiagnosis of POI is common and 25% of women say their diagnosis took more than 5 years and 50% or more will see three or more specialists before diagnosis is it a wonder it creates so much angst?

It is important to note that 25 % of women with POI do not experience these symptoms initially as their younger physiology can compensate but may at a later stage. Due to health issues and other conditions associated with POI, the average life expectancy of a woman with POI is 2 years less. The immediate threats to this younger group of women are mental health, fertility, and sexual functioning which impacts their relationships and well-being. Immediate support and focus is paramount to effective care.

Addressing the stigma of menopause in society and women themselves feeling it is a taboo subject is a fundamental but symbiotic shift. Women need to empower and be empowered. How can this translate into the workplace so we can optimise the necessary support and create a culture of menopause dignity? There needs to be a greater sensitivity with POI as these women bear a greater psychological burden with other underlying health conditions and the big fertility issue. They may also be at a time where they are developing their careers, feel they need to prove themselves, and have economic and family pressures which the older menopausal women is beyond. In summary, the needs of women with POI are complex and different and employers may not link menopause with their younger employees, who are suffering in silence. It is recognised that open communication and changes to the working environment can go far in reducing the impact of someones symptoms.

Employers have a corporate social responsibility to formulate HR policies and practices to support menopause and POI in the workplace. Every manager and employer should have access to high-quality information and education about menopause and POI issues to enable appropriate support of their teams. This ensures menopause gets the same understanding as any other health issue which will boost morale, retain valuable skills and talent and reduce sickness absence. Good communication skills such as sensitivity, empathy, active listening and non-judgement will encourage women to talk with honesty. Open communication must be facilitated with conversations about relevant issues to break down barriers so gauging and promoting awareness.

Performance must be managed proactively and positively with attention paid to the root cause if there appears to be a problem. The approach should be positive and supportive, taking into account underlying health conditions. Extra support and coaching can then be identified and reasonable time scales for improvement can be set. Regular informal dialogue will build trust and improve resilience.

Employers have a legal duty to ensure proper working conditions and remove discriminatory barriers to progression for women. Organisations such as CIPD and ACAS provide guidelines and resources on how to develop menopause policy in the workplace.

Psychological issues are prevalent in POI, and women must be empowered to discuss concerns with their line manager so adjustments can be made to work duties causing a particular challenge. Some companies have employed a menopause or wellbeing champion for this purpose so women can be directed to relevant counselling services and seek medical advice. Women with POI must be seen in a specialist clinic and ideally offered bioidentical hormone replacement therapy tailored to their needs, holistic support for immediate problems such as sexual dysfunction and monitoring of long term health conditions such as DEXA bone scans to assess osteoporosis risk. POI women might need time off for fertility treatments such as IVF and egg donation which can be extremely stressful and there is no guarantee of success for the amount of emotional and financial investment pumped in. The Daisy Network is a charity dedicated to providing information and support for POI.

Employers must identify reasonable adjustments that can create an inclusive space for women and there must be capacity for risk assessment for each individual employee. Easy access to washrooms and sanitary products should be considered. Changes such as moving a desk to the window, ensuring ergonomics of the workspace, providing fans, cool drinking water and regular rest breaks are a welcome relief for problematic symptoms and engender goodwill. Flexible working patterns are important such as part-time working and surely the ability to work from home rather than taking a day off is a better solution to workplace productivity. There has been a huge culture shift in working from home due to the current pandemic. Zoom has boomed! We have been positively coerced into making productive work arrangements and the benefits and possibilities in our digital age are vast.

Women comprise 50% of the UK workforce represented in all sectors and at all levels including top executive and governmental positions indeed the country voted as having the best response to the coronavirus pandemic has Jacinda Ardern, the youngest female prime minister at its helm! What a role model for the world. A 21st-centuryenvironment should be inclusive to both sexes and enable us to rightfully thrive in the workplace and community.

Editor's Recommended Articles

Originally posted here:
Suffering with Premature Ovarian Insufficiency (POI) in the workplace - Open Access Government

Posted in Hormone Replacement Therapy | Comments Off on Suffering with Premature Ovarian Insufficiency (POI) in the workplace – Open Access Government

Hormone Replacement Therapy Market Size, Growth And Key Players- Eli Lilly, Teva, Novo Nordisk, Pfizer, Bayer The Bisouv Network – The Bisouv Network

Posted: February 19, 2021 at 1:47 am

Fort Collins, Colorado: Reports Globe added the latest research report on future growth opportunities, development trends, and forecasts for 2027 of the Hormone Replacement Therapy Market. Global Hormone Replacement Therapy Market Report provides an overview of the segments and sub-segments including Product Types, Applications, Companies, and Regions. This report describes the overall size of the Hormone Replacement Therapy market through analysis of historical data and future forecasts.

The report presents unique and pertinent factors that are expected to have a material impact on the Hormone Replacement Therapy market during the forecast period. This report also provides an analysis of the impact of the COVID-19 pandemic on the Hormone Replacement Therapy market. This report contains a substantial and detailed amount of information that will provide new entrants with the most complete understanding. The report explains the historical and current trends that are shaping the growth of the Hormone Replacement Therapy market.

(Exclusive Offer: Flat 30% discount on this report)

Request a Sample Before Buying this Report @ https://reportsglobe.com/download-sample/?rid=105100

The Following Companies are Major Contributors to the Hormone Replacement Therapy Market Research Report:

Segment Analysis

The report categorizes the Hormone Replacement Therapy industry by segment, including product type and application. Each segment is valued based on its growth rate and share. In addition, analysts examined potential regions that could prove useful for Hormone Replacement Therapy manufacturers in the coming years. The regional analysis includes reliable value and volume forecasts and thus helps market participants to better understand the Hormone Replacement Therapy industry as a whole.

Hormone Replacement Therapy Market Segmentation, By Type

Hormone Replacement Therapy Market Segmentation, By Application

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=105100

Geographical scenario:

-Middle East and Africa (Gulf States and Egypt)-North America (USA, Mexico and Canada)-South America (Brazil etc.)-Europe (Turkey, Germany, Russia, UK, Italy, France, etc.)-Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Scope of the Report:

The Hormone Replacement Therapy Market Research Report is a comprehensive publication that aims to determine the financial outlook for the market. For the same reason, it offers a detailed understanding of the competitive landscape. It examines some of the leading players, their leadership styles, their status in research and development, and their expansion strategies.

The report also includes product portfolios and a list of products in development. It provides a detailed explanation of the advanced technologies and investments to upgrade existing technologies.

Collectively, this research repository encapsulates data of Hormone Replacement Therapy market to offer strategic decision-making abilities to various investors, business owners, decision-makers as well as policymakers.

View market snapshot before purchasing @ https://reportsglobe.com/product/global-hormone-replacement-therapy-market-insight-and-forecast/

Key questions answered in the report:

1. What is the Keyword Markets Growth Potential?2. Which product segment will get the lions share?3. Which regional market will lead in the coming years?4. Which application segment will grow steadily?5. What growth opportunities could arise in the Hormone Replacement Therapy industry in the coming years?6. What are the main challenges for the Hormone Replacement Therapy market in the future?7. Which companies lead the Hormone Replacement Therapy market?8. What are the main trends that are positively influencing market growth?9. What growth strategies are players considering to stay in the Hormone Replacement Therapy market?

Table of Contents

1 scope of research2 summary3 Competition from manufacturers4 Market size by type5 Market size by application6 Market Size by Region7 Company profileEight value chain and sales channel analyzes9 Analysis of market drivers, opportunities, challenges and risk factors10 key findings from the Hormone Replacement Therapy study11 Appendix

Request customization of the report @ https://reportsglobe.com/need-customization/?rid=105100

Key target audience for Hormone Replacement Therapy report:

The report is insightful documentation and provides significant insights to customers, business owners, decision-makers, providers, distributors, suppliers, policymakers, manufacturers, investors, and individuals who have a keen interest in the Hormone Replacement Therapy market.

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Sarkari Results, Thrive Market Research

Originally posted here:
Hormone Replacement Therapy Market Size, Growth And Key Players- Eli Lilly, Teva, Novo Nordisk, Pfizer, Bayer The Bisouv Network - The Bisouv Network

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy Market Size, Growth And Key Players- Eli Lilly, Teva, Novo Nordisk, Pfizer, Bayer The Bisouv Network – The Bisouv Network

Bio-identical Hormone Replacement Therapy Market Size, Growth And Key Players- RevitaLife, US Compounding, Aesthetics&Wellness, The Bisouv Network -…

Posted: February 19, 2021 at 1:47 am

Fort Collins, Colorado: Reports Globe added the latest research report on future growth opportunities, development trends, and forecasts for 2027 of the Bio-identical Hormone Replacement Therapy Market. Global Bio-identical Hormone Replacement Therapy Market Report provides an overview of the segments and sub-segments including Product Types, Applications, Companies, and Regions. This report describes the overall size of the Bio-identical Hormone Replacement Therapy market through analysis of historical data and future forecasts.

The report presents unique and pertinent factors that are expected to have a material impact on the Bio-identical Hormone Replacement Therapy market during the forecast period. This report also provides an analysis of the impact of the COVID-19 pandemic on the Bio-identical Hormone Replacement Therapy market. This report contains a substantial and detailed amount of information that will provide new entrants with the most complete understanding. The report explains the historical and current trends that are shaping the growth of the Bio-identical Hormone Replacement Therapy market.

(Exclusive Offer: Flat 30% discount on this report)

Request a Sample Before Buying this Report @ https://reportsglobe.com/download-sample/?rid=102995

The Following Companies are Major Contributors to the Bio-identical Hormone Replacement Therapy Market Research Report:

Segment Analysis

The report categorizes the Bio-identical Hormone Replacement Therapy industry by segment, including product type and application. Each segment is valued based on its growth rate and share. In addition, analysts examined potential regions that could prove useful for Bio-identical Hormone Replacement Therapy manufacturers in the coming years. The regional analysis includes reliable value and volume forecasts and thus helps market participants to better understand the Bio-identical Hormone Replacement Therapy industry as a whole.

Bio-identical Hormone Replacement Therapy Market Segmentation, By Type

Bio-identical Hormone Replacement Therapy Market Segmentation, By Application

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=102995

Geographical scenario:

-Middle East and Africa (Gulf States and Egypt)-North America (USA, Mexico and Canada)-South America (Brazil etc.)-Europe (Turkey, Germany, Russia, UK, Italy, France, etc.)-Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Scope of the Report:

The Bio-identical Hormone Replacement Therapy Market Research Report is a comprehensive publication that aims to determine the financial outlook for the market. For the same reason, it offers a detailed understanding of the competitive landscape. It examines some of the leading players, their leadership styles, their status in research and development, and their expansion strategies.

The report also includes product portfolios and a list of products in development. It provides a detailed explanation of the advanced technologies and investments to upgrade existing technologies.

Collectively, this research repository encapsulates data of Bio-identical Hormone Replacement Therapy market to offer strategic decision-making abilities to various investors, business owners, decision-makers as well as policymakers.

View market snapshot before purchasing @ https://reportsglobe.com/product/global-bio-identical-hormone-replacement-therapy-market-insight-and-forecast/

Key questions answered in the report:

1. What is the Keyword Markets Growth Potential?2. Which product segment will get the lions share?3. Which regional market will lead in the coming years?4. Which application segment will grow steadily?5. What growth opportunities could arise in the Bio-identical Hormone Replacement Therapy industry in the coming years?6. What are the main challenges for the Bio-identical Hormone Replacement Therapy market in the future?7. Which companies lead the Bio-identical Hormone Replacement Therapy market?8. What are the main trends that are positively influencing market growth?9. What growth strategies are players considering to stay in the Bio-identical Hormone Replacement Therapy market?

Table of Contents

1 scope of research2 summary3 Competition from manufacturers4 Market size by type5 Market size by application6 Market Size by Region7 Company profileEight value chain and sales channel analyzes9 Analysis of market drivers, opportunities, challenges and risk factors10 key findings from the Bio-identical Hormone Replacement Therapy study11 Appendix

Request customization of the report @ https://reportsglobe.com/need-customization/?rid=102995

Key target audience for Bio-identical Hormone Replacement Therapy report:

The report is insightful documentation and provides significant insights to customers, business owners, decision-makers, providers, distributors, suppliers, policymakers, manufacturers, investors, and individuals who have a keen interest in the Bio-identical Hormone Replacement Therapy market.

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Sarkari Results, Thrive Market Research

Read the original post:
Bio-identical Hormone Replacement Therapy Market Size, Growth And Key Players- RevitaLife, US Compounding, Aesthetics&Wellness, The Bisouv Network -...

Posted in Hormone Replacement Therapy | Comments Off on Bio-identical Hormone Replacement Therapy Market Size, Growth And Key Players- RevitaLife, US Compounding, Aesthetics&Wellness, The Bisouv Network -…

Cork woman told she would never have children celebrates baby joy and clean bill of health 3 years after shock cancer diagnosis – EchoLive.ie

Posted: February 19, 2021 at 1:47 am

A CORK woman is marking three years of being cancer-free with a new baby and a fundraiser for the charity that was her safe place while she was sick.

Nuala OBrien was just 23 when she by chance discovered that she had cancer after a fall on a night out.

The Glanworth native cut her hand went to A&E where a student staff member she got chatting to asked if she could practice conducting a chest X-ray.

The X-ray would reveal that 23-year-old Nuala had Hodgkins lymphoma.

Diagnosed with stage 2 cancer, Nuala was told that if it had not been detected when it was, she may not have lived to see her birthday which was just six months away.

They said that because I had no symptoms and how fast it was growing, I probably wouldnt have seen my birthday in the April, so I was lucky I fell when I did, she said.

When she was first diagnosed, her family had been persuading her to attend the Cork Cancer Care Centre, but she had been reluctant.

However, after a relapse, she decided to try it out and it quickly became her safe place.

I was only 23 when I first got diagnosed and I didnt know anybody else that had cancer, she said.

When I was out in public and I was out with other people, I was the only sick person and it was really obvious that I was sick and people would give you a look and people are always asking how you are getting on whereas when you get into the centre, everyone is like that and no one talks about being sick.

The Cork Cancer Care Centre was founded in 2011 and acts as a home away from home for those who have touched by cancer, with a number of supports for families and individuals.

It was kind of like a safe place that you could go and be normal and not have everyone feel sorry for you, she added.

During her treatment, Nuala had experienced menopause at just 24-years of age.

I was told I would never have kids and I was put straight on hormone replacement therapy patches just to help with the side effects of menopause.and then I just kind of accepted that I could never have kids.

However, shortly after celebrating her second year of being cancer-free, she discovered that she was pregnant with baby Shay.

Each Valentines Day, Nuala marks her anniversary of being cancer-free by raising money for the centre and this year, she celebrated the three-year mark alongside her seven-month-old son, Shay.

Over the past number of years, she has experienced a lot of unexpected changes in life, but her support for the Cork Cancer Care Centre will continue throughout the years of celebrating the important milestone.

Its a charity that I know forever will be really, really close to our hearts and that we will always be doing as much as we can for them because they have done so much for us. Donations can be made on @togetherwearestandinguptocancer on Facebook or on corkcancercarecentre.ie.

See the rest here:
Cork woman told she would never have children celebrates baby joy and clean bill of health 3 years after shock cancer diagnosis - EchoLive.ie

Posted in Hormone Replacement Therapy | Comments Off on Cork woman told she would never have children celebrates baby joy and clean bill of health 3 years after shock cancer diagnosis – EchoLive.ie

Page 764«..1020..763764765766..770780..»